Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Cardiology

Understanding Test Results and Risk Scores

At a Glance

After a myocardial infarction, no single test tells the whole story: serial troponin and ECG help confirm acute injury, while LVEF, Killip class, GRACE score, and, when needed, cardiac MRI show heart function, severity, likely cause, and recovery needs.

Medical records can often feel like an overwhelming “alphabet soup” of scores and numbers. However, understanding these results is one of the most powerful ways to participate in your own recovery. These tests tell the story of how your heart was affected and help your care team predict how it will heal.

Confirming the Diagnosis: ECG and Troponin

To confirm a heart attack, doctors use two primary tools: the electrocardiogram (ECG) and the high-sensitivity troponin (hs-cTn) test.

  • ECG: This measures your heart’s electrical activity. It is the first tool used to categorize your heart attack (such as a STEMI) and determines how quickly you need an intervention [1].
  • Serial Troponin: Troponin is a protein released when heart muscle is damaged. To diagnose a heart attack, doctors look for a “rise and/or fall” in these levels across multiple tests (serial testing). Crucially, the value must be above the assay-specific 99th-percentile upper reference limit [2][3].
  • Injury vs. Infarction: It is important to know that a single high troponin level, or a chronic elevation, does not automatically mean you had a heart attack. A high level shows myocardial injury, which can be caused by many things (like kidney stress, pulmonary embolism, or sepsis). A true heart attack (infarction) requires that acute injury plus evidence that the heart was starved of oxygen, such as symptoms, imaging, or ECG changes [4][2].

Pumping Power: LVEF

Left Ventricular Ejection Fraction (LVEF) is a measurement of how much blood your heart’s main pumping chamber pushes out with each beat. It is a critical marker for your long-term health, though it is only one measure of cardiac function and does not alone define heart failure or your future [5].

  • Preserved/Normal Range (generally ≥50%): The heart is pumping a normal percentage of blood.
  • Mildly Reduced (41–49%): The pumping power is slightly lower than normal [6].
  • Reduced (≤40%): The heart is struggling to pump effectively. This often requires specific medications—such as beta-blockers, ACE inhibitors, ARNIs, MRAs, or SGLT2 inhibitors—to help the heart muscle recover depending on your clinical picture [5][7].
  • Recovery: Your LVEF can improve as your heart heals. Doctors often suggest repeat imaging (like an echocardiogram) after an individualized period of recovery, revascularization, or medication optimization (often around >40 days to 3 months) to reassess function [8][9].

Measuring Severity: Killip Class and GRACE Score

Doctors use standardized clinical assessments to describe how serious a heart attack is and to decide on the best treatment path.

  • Killip Class (I–IV): This is a clinical snapshot of heart failure symptoms during your hospital stay. It is not a permanent label [10].
    • Class I: No signs of heart failure.
    • Class II: Mild heart failure (e.g., fluid/crackles in the lungs or an extra heart sound indicating elevated pressure).
    • Class III: Severe heart failure (frank pulmonary edema).
    • Class IV: Cardiogenic shock (the heart cannot pump enough blood to support the body) [10][11].
  • GRACE Score: This risk-prediction tool primarily for NSTE-ACS calculates your risk of future heart problems based on factors like age, heart rate, and blood pressure [12]. A score over 140 is considered “high risk” and informs, but does not alone mandate, clinical decisions like scheduling an angiogram within 24 hours [13][12].

The Role of Cardiac MRI in MINOCA

If your angiogram showed no major obstructive blockages but you still met criteria for a heart attack (MINOCA), a Cardiac MRI (CMR) is a key diagnostic step [14]. This specialized scan looks deep into the heart tissue to help find the real cause:

  • Ischemic Pattern: Identifies an ischemic pattern of myocardial injury, suggesting a clot, spasm, or microvascular issue was the cause (though CMR alone often cannot pinpoint the exact coronary mechanism).
  • Myocarditis or Takotsubo: Shows the injury was actually caused by inflammation of the heart muscle or stress-induced “ballooning.” If found, patients are generally reclassified as having these conditions rather than true MINOCA [15][16].
    A CMR performed early is much more likely to provide a clear answer than one performed months later [17].

Your Discharge Summary Checklist

Before you leave the hospital, ensure your discharge summary includes these essential details.

Essential Item Why It Matters
Final Diagnosis Specifies if it was a STEMI/NSTEMI and the suspected mechanism (Type 1, Type 2, MINOCA/mimic).
LVEF Percentage Your baseline heart function for future comparisons.
Killip Class Records the severity of your initial presentation.
Medication List Names, dosages, and instructions for how long to take them.
Procedure Details Locations of any stents and the results of your angiogram.
Follow-up Plan Dates for your first cardiology visit and repeat heart imaging.
Cardiac Rehab A formal referral to a recovery program.

(References for Checklist: [18][19][20])

Common questions in this guide

Does a high troponin level always mean I had a heart attack?
No. Troponin shows that heart muscle has been injured, but levels can also rise with kidney problems, a blood clot in the lungs, sepsis, or other conditions. Doctors diagnose a heart attack when an acute rise or fall in troponin is paired with evidence that the heart lacked oxygen, such as symptoms, ECG changes, or imaging.
What does my LVEF percentage mean after a heart attack?
LVEF is the percentage of blood pumped out of the heart’s main chamber with each beat. An LVEF of about 50% or higher is generally preserved, 41–49% is mildly reduced, and 40% or lower is reduced. LVEF can improve as the heart heals, so your clinician may recommend a repeat echocardiogram.
What do Killip class and GRACE score tell me?
Killip class records how much heart failure was present during the hospital stay, from Class I with no signs to Class IV with cardiogenic shock, and it is not a permanent label. The GRACE score estimates the risk of future heart problems in people with non-ST-elevation acute coronary syndrome using information such as age, heart rate, and blood pressure. A score above 140 is considered high risk, but it supports rather than replaces clinical judgment.
Why might I need a cardiac MRI if I have MINOCA?
When an angiogram shows no major blockage but the heart still meets criteria for a heart attack, cardiac MRI can show whether the injury follows an ischemic pattern or is due to myocarditis or Takotsubo syndrome. An early scan is more likely to clarify the cause. If the findings indicate myocarditis or Takotsubo syndrome, doctors generally reclassify the condition rather than call it true MINOCA.
What should be included in my heart attack discharge summary?
The summary should record your final diagnosis, such as STEMI, NSTEMI, Type 1 or Type 2 myocardial infarction, or MINOCA; your LVEF and Killip class; medication instructions; angiogram and stent details; follow-up and repeat imaging; and a cardiac rehabilitation referral. Ask for a copy before leaving and request an explanation of anything you do not understand.
Can my heart’s pumping function recover after a heart attack?
Yes, LVEF can improve as the heart heals, after blood flow is restored, or after medicines are adjusted. Your clinician may repeat an echocardiogram after an individualized recovery period, often from more than 40 days to 3 months. The timing depends on your heart function, treatment, and overall condition.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was the peak value of my high-sensitivity troponin, and how did it change between the first and second tests?
  2. 2.What was my LVEF measured at during this stay, and do we need to repeat the imaging in the coming months to see if it improves?
  3. 3.What was my GRACE score at admission, and how did that score inform the clinical decisions during my stay?
  4. 4.If my diagnosis is MINOCA, does my cardiac MRI show an ischemic pattern, or a non-ischemic pattern like myocarditis?
  5. 5.Based on my Killip class during the first 24 hours, what should I know about my risk for heart failure in the coming months?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Rural and Remote Acute STEMI Diagnosis and Management: Current Status and Future Directions.

    Gadeley R, Arnold R, Amos D, et al.

    Heart, lung & circulation 2025; (34(12)):1332-1343 doi:10.1016/j.hlc.2025.06.1035.

    PMID: 40897570
  2. 2

    Analytical Considerations in Deriving 99th Percentile Upper Reference Limits for High-Sensitivity Cardiac Troponin Assays: Educational Recommendations from the IFCC Committee on Clinical Application of Cardiac Bio-Markers.

    Aakre KM, Saenger AK, Body R, et al.

    Clinical chemistry 2022; (68(8)):1022-1030 doi:10.1093/clinchem/hvac092.

    PMID: 35716089
  3. 3

    High-sensitivity cardiac troponin assays: From improved analytical performance to enhanced risk stratification.

    Kozinski M, Krintus M, Kubica J, Sypniewska G

    Critical reviews in clinical laboratory sciences 2017; (54(3)):143-172 doi:10.1080/10408363.2017.1285268.

    PMID: 28457177
  4. 4

    Methodological evaluation and clinical interpretation of hs-cTnI and hs-cTnT variations: a reappraisal.

    Clerico A, Zaninotto M, Plebani M

    Clinical chemistry and laboratory medicine 2026; (64(3)):566-569 doi:10.1515/cclm-2025-1318.

    PMID: 41139936
  5. 5

    Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.

    Bozkurt B, Coats AJS, Tsutsui H, et al.

    European journal of heart failure 2021; (23(3)):352-380 doi:10.1002/ejhf.2115.

    PMID: 33605000
  6. 6

    Evaluation of acute myocardial infarction patients with mid-range ejection fraction after emergency percutaneous coronary intervention.

    Jiang Y, Hu S, Cao M, et al.

    Postgraduate medical journal 2019; (95(1125)):355-360 doi:10.1136/postgradmedj-2018-136334.

    PMID: 31129629
  7. 7

    Predictors of the Use of Mineralocorticoid Receptor Antagonists in Patients With Left Ventricular Dysfunction Post-ST-Segment-Elevation Myocardial Infarction.

    Wong EC, Fordyce CB, Wong G, et al.

    Journal of the American Heart Association 2021; (10(14)):e019167 doi:10.1161/JAHA.120.019167.

    PMID: 34227405
  8. 8

    Change in Left Ventricular Ejection Fraction Following First Myocardial Infarction and Outcome.

    Chew DS, Heikki H, Schmidt G, et al.

    JACC. Clinical electrophysiology 2018; (4(5)):672-682 doi:10.1016/j.jacep.2017.12.015.

    PMID: 29798797
  9. 9

    Effect of Guideline-Based Therapy on Left Ventricular Systolic Function Recovery After ST-Segment Elevation Myocardial Infarction.

    Abou R, Leung M, Goedemans L, et al.

    The American journal of cardiology 2018; (122(10)):1591-1597 doi:10.1016/j.amjcard.2018.07.035.

    PMID: 30213383
  10. 10

    Killip-Kimball classification in octogenarians with acute coronary syndrome: An 11-year experience.

    Ramonfaur D, Hinojosa-González DE, Paredes-Vázquez JG

    Archivos de cardiologia de Mexico 2022; (92(4)):425-430 doi:10.24875/ACM.21000046.

    PMID: 35144335
  11. 11

    N-terminal pro-B-type natriuretic peptide and pulmonary echography are predictors of acute heart failure needing early mechanical ventilation in acute coronary syndrome.

    Cristo-Ropero MJ, Garcia-Rubira JC, Rivera-Rabanal FJ, et al.

    Coronary artery disease 2024; (35(7)):556-563 doi:10.1097/MCA.0000000000001396.

    PMID: 38828510
  12. 12

    Risk stratification in non-ST elevation acute coronary syndromes: Risk scores, biomarkers and clinical judgment.

    Corcoran D, Grant P, Berry C

    International journal of cardiology. Heart & vasculature 2015; (8()):131-137 doi:10.1016/j.ijcha.2015.06.009.

    PMID: 26753174
  13. 13

    Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.

    Kofoed KF, Kelbæk H, Hansen PR, et al.

    Circulation 2018; (138(24)):2741-2750 doi:10.1161/CIRCULATIONAHA.118.037152.

    PMID: 30565996
  14. 14

    Troponin-Positive Non-Obstructive Coronary Arteries and Myocardial Infarction with Non-Obstructive Coronary Arteries: Definition, Etiologies, and Role of CT and MR Imaging.

    Yoo SM, Jang S, Kim JA, Chun EJ

    Korean journal of radiology 2020; (21(12)):1305-1316 doi:10.3348/kjr.2020.0064.

    PMID: 32783414
  15. 15

    Diagnostic Value of Cardiac Magnetic Resonance Imaging and Intracoronary Optical Coherence Tomography in Patients With a Working Diagnosis of Myocardial Infarction With Non-obstructive Coronary Arteries - A Systematic Review and Meta-analysis.

    Machanahalli Balakrishna A, Ismayl M, Thandra A, et al.

    Current problems in cardiology 2023; (48(6)):101126 doi:10.1016/j.cpcardiol.2022.101126.

    PMID: 35120967
  16. 16

    A novel multimodal imaging approach for working diagnosis of acute myocardial infarction with non-obstructive coronary arteries: a promising diagnostic strategy.

    Taverna G, Canton L, Zilio L, et al.

    Frontiers in cardiovascular medicine 2025; (12()):1646418 doi:10.3389/fcvm.2025.1646418.

    PMID: 41584294
  17. 17

    Early Comprehensive Cardiovascular Magnetic Resonance Imaging in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries.

    Sörensson P, Ekenbäck C, Lundin M, et al.

    JACC. Cardiovascular imaging 2021; (14(9)):1774-1783 doi:10.1016/j.jcmg.2021.02.021.

    PMID: 33865778
  18. 18

    [4th universal definition of myocardial infarction 2018 : What is new?]

    Brinkmann C, Schofer J

    Herz 2018; (43(8)):681-688 doi:10.1007/s00059-018-4763-6.

    PMID: 30334064
  19. 19

    Clinical impact of cardiac magnetic resonance imaging in myocardial infarction with non-obstructive coronary arteries: a prospective multicentre cohort study.

    Rajwani A, Giudicatti L, Telyuk P, et al.

    Heart (British Cardiac Society) 2025; (112(2)):95-102 doi:10.1136/heartjnl-2024-325181.

    PMID: 40514208
  20. 20

    Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery Disease.

    Paolisso P, Bergamaschi L, Saturi G, et al.

    Frontiers in pharmacology 2019; (10()):1606 doi:10.3389/fphar.2019.01606.

    PMID: 32082147

This page is for informational purposes only and does not constitute medical advice. Your cardiology team should interpret your ECG, troponin, LVEF, and risk scores in the context of your care.

Get notified when new evidence is published on myocardial infarction.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.